Come see what’s new at Accelis Pharma.

OBREDON™ Oral Solution

OBREDON™ (hydrocodone bitartrate and Guaifenesin) Oral Solution (CII) is a combination product containing an opioid antitussive and expectorant indicated for symptomatic relief of cough and to loosen mucus associated with the common cold in adults and adolescents 18 years of age and older.

OBREDON™ Oral Solution is contraindicated in individuals with hypersensitivity to hydrocodone bitartrate, guaifenesin, or any of the inactive ingredients; individuals receiving monoamine oxidase inhibitor (MAOI) therapy or within 14 days of stopping such therapy. Exercise caution when using because of the potential for respiratory depression. OBREDON™ Oral Solution is a Schedule II controlled prescription containing hydrocodone bitartrate and should be prescribed and administered with caution, particularly in patient with history of drug dependence as there is the possibility of psychic dependence, physical dependence and/or tolerance. Abuse of guaifenesin has been linked to formation of kidney stones.


Lidocaine 2.5% and prilocaine 2.5% cream (a eutectic mixture of lidocaine 2.5% and prilocaine 2.5%) is indicated as a topical anesthetic for use on:
normal intact skin for local analgesia.
genital mucous membranes for superficial minor surgery and as pretreatment for infiltration anesthesia.